Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Osteoporos Rep. 2011 Mar;9(1):4-5. doi: 10.1007/s11914-010-0044-x.

Defining zoledronate's duration of action and optimal dosing interval for an effective therapy.

Author information

  • Medical Director Cedars-Sinai Bone Center of Excellence, David Geffen School of Medicine UCLA, 8641 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA. stuarts@omcresearch.org

Comment on

PMID:
21161452
[PubMed]
PMCID:
PMC3026771
Free PMC Article

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk